DE68918681T2 - Glycosidasehemmer. - Google Patents

Glycosidasehemmer.

Info

Publication number
DE68918681T2
DE68918681T2 DE68918681T DE68918681T DE68918681T2 DE 68918681 T2 DE68918681 T2 DE 68918681T2 DE 68918681 T DE68918681 T DE 68918681T DE 68918681 T DE68918681 T DE 68918681T DE 68918681 T2 DE68918681 T2 DE 68918681T2
Authority
DE
Germany
Prior art keywords
glycosidase inhibitors
glycosidase
allitol
dideoxy
imino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918681T
Other languages
English (en)
Other versions
DE68918681D1 (de
Inventor
George William John Fleet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DE68918681D1 publication Critical patent/DE68918681D1/de
Application granted granted Critical
Publication of DE68918681T2 publication Critical patent/DE68918681T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68918681T 1988-12-22 1989-12-21 Glycosidasehemmer. Expired - Fee Related DE68918681T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/288,735 US4894388A (en) 1988-12-22 1988-12-22 Glycosidase inhibitors and use thereof

Publications (2)

Publication Number Publication Date
DE68918681D1 DE68918681D1 (de) 1994-11-10
DE68918681T2 true DE68918681T2 (de) 1995-03-30

Family

ID=23108416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918681T Expired - Fee Related DE68918681T2 (de) 1988-12-22 1989-12-21 Glycosidasehemmer.

Country Status (7)

Country Link
US (1) US4894388A (de)
EP (1) EP0375651B1 (de)
JP (1) JP2948847B2 (de)
AT (1) ATE112558T1 (de)
CA (1) CA2006269C (de)
DE (1) DE68918681T2 (de)
ES (1) ES2064487T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043416A (en) * 1988-09-26 1991-08-27 Monsanto Company Method of inhibiting virus
US5013842A (en) * 1990-01-22 1991-05-07 Monsanto Company Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors
US5863903A (en) * 1994-03-09 1999-01-26 Novo Nordisk A/S Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
EP0749423B1 (de) * 1994-03-09 2003-06-18 Novo Nordisk A/S Piperidine und pyrrolidine
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
EP0884050A1 (de) 1995-09-08 1998-12-16 Novo Nordisk A/S Verwendung von 3,4-dihydroxy-2-hydroxymethylpyrrolidin zur behandlung von diabetes
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
EP1023290A1 (de) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthese von swainsoninsalzen
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
DE60037664T2 (de) * 1999-08-10 2008-12-24 The Chancellor, Masters And Scholars Of The University Of Oxford Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel
CA2616537A1 (en) 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
EP2049126A2 (de) 2006-08-02 2009-04-22 United Therapeutics Corporation Liposomen-behandlung von virusinfektionen
WO2008063727A2 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
WO2010109330A2 (en) * 2009-03-27 2010-09-30 University Of Oxford Cholesterol level lowering liposomes
IN2012DN00352A (de) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
WO2012174064A1 (en) 2011-06-14 2012-12-20 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
EP2768307B1 (de) 2011-10-19 2020-03-18 Bikam Pharmaceuticals, Inc. Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür
EP2944628B1 (de) 2011-11-30 2017-01-04 Bikam Pharmaceuticals, Inc. Opsinbindende liganden, zusammensetzungen und verfahren zur verwendung
WO2013081642A1 (en) 2011-12-01 2013-06-06 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CN107613990B (zh) * 2015-03-27 2021-03-26 康奈尔大学 烟酰胺单核苷酸的有效合成

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312716A (en) * 1964-08-11 1967-04-04 Aldrich Chem Co Inc 4-hydroxy-3-pyrrolidinemethanols
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
CA2006269A1 (en) 1990-06-22
DE68918681D1 (de) 1994-11-10
JPH02212470A (ja) 1990-08-23
EP0375651A1 (de) 1990-06-27
EP0375651B1 (de) 1994-10-05
JP2948847B2 (ja) 1999-09-13
CA2006269C (en) 1998-09-15
US4894388A (en) 1990-01-16
ES2064487T3 (es) 1995-02-01
ATE112558T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
DE68918681D1 (de) Glycosidasehemmer.
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
DK1090914T3 (da) Forbindelser, der inhiberer retroviral protease
ES2054712T3 (es) Un procedimiento para la preparacion de los derivados de prolinal.
DK249089D0 (da) Benzamid-forbindelser, der er nyttige som protease-inhibitorer
DK345989A (da) Quinolinderivater
DK506587D0 (da) Imidderivater
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
DK0791007T3 (da) Antifungale sordaridinderivater
ATE84787T1 (de) Prolin-derivate.
DK0747392T3 (da) Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner
AR241157A2 (es) Derivados de la imida del acido n-fenil-3,4,5,6-tetrahidroftalico, procedimiento para su preparacion y composiciones que los contienen
DK0406211T3 (da) Fucosidase-inhibitorer
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
ATE72435T1 (de) Derivate von phenyl-, pyrrolidin-2-ylsubstituierten 5-ring heterocyclen mit antipsychotischer wirkung.
ATE73768T1 (de) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8inter-m-phenylene-pgi2-derivate.
ATE53996T1 (de) Antiarrhythmische mittel.
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
NO942668L (no) Alkylderivater av trazodon med CNS-aktivitet
ATE65986T1 (de) Propanolabkoemmlinge.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
SU1351063A1 (ru) Производные 2-тиазолзамещенного 5-нитрофурана, проявляющие антистафилококковую активность

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee